Literature DB >> 29752140

Feiji Recipe inhibits the growth of lung cancer by modulating T-cell immunity through indoleamine-2,3-dioxygenase pathway in an orthotopic implantation model.

Bin Luo1, Zu-Jun Que2, Zhi-Yi Zhou1, Qing Wang2, Chang-Sheng Dong2, Yi Jiang1, Bing Hu3, Hui Shi4, Yu Jin4, Jian-Wen Liu4, He-Gen Li1, Lin Wang5, Jian-Hui Tian6.   

Abstract

OBJECTIVE: Escape from the body's immune response is a basic characteristic of lung cancer, and indoleamine-2,3-dioxygenase (IDO) plays a key role in mediating immune escape of non-small-cell lung cancer, which leads to recurrence and metastasis. Feiji Recipe, a compound Chinese herbal medicine, has the effect of stabilizing lesions and prolonging survival in patients with lung cancer. The purpose of this study was to investigate the mechanisms underlying the anticancer properties of Feiji Recipe.
METHODS: An orthotopic transplant model of mouse Lewis lung cancer, with stable expression of IDO gene, was established in C57BL/6 mice. Optical imaging was used to observe the effects of Feiji Recipe in the treatment of lung cancer in vivo. The effects of Feiji Recipe on the proliferation of mouse Lewis lung cancer cell line 2LL, 2LL-enhanced green fluorescent protein (2LL-EGFP) and 2LL-EGFP-IDO were investigated, and the apoptosis of T-cells was examined by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide using flow cytometry. Chemical composition of Feiji Recipe was validated by high-performance liquid chromatography.
RESULTS: Compared to the control group, the survival of animals treated with Feiji Recipe was significantly prolonged (P = 0.0074), and the IDO protein level decreased (P = 0.0072); moreover, the percentages of CD4+CD25+ T-cells and Foxp3+ T-cells were significantly decreased (P < 0.05). The molecular mechanism of Feiji Recipe against lung cancer may relate to the regulation of immune cells, such as T-cells and regulatory T-cells.
CONCLUSION: The molecular mechanism of Feiji Recipe in treatment of lung cancer is to restore the function of T-cells in the cancer microenvironment through interfering with the IDO pathway.
Copyright © 2018 Shanghai Changhai Hospital. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Feiji Recipe; Immune escape; Indoleamine-2,3-dioxygenase; Orthotopic xenografts

Mesh:

Substances:

Year:  2018        PMID: 29752140     DOI: 10.1016/j.joim.2018.04.008

Source DB:  PubMed          Journal:  J Integr Med


  8 in total

1.  HLX affects cell cycle and proliferation in AML cells via the JAK/STAT signaling pathway.

Authors:  Xia-Yin Zhu; Qun-Yi Guo; Min Zhu; Bao-Guo Chen; Ling-Yan Wang; Dan-Qiong Zhang; Li Zhang; Yan-Ping Shao; Wen-Da Luo
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

2.  Identification of the Active Compounds and Significant Pathways of Artemisia Annua in the Treatment of Non-Small Cell Lung Carcinoma based on Network Pharmacology.

Authors:  Shu Qiao Zhang; Hai Bo Xu; Shi Jun Zhang; Xin Yu Li
Journal:  Med Sci Monit       Date:  2020-05-31

3.  Cancer inhibition mechanism of lung cancer mouse model based on dye trace method.

Authors:  Wei Zhang; Hongyan Shu; Lixin Fang; Ning Tang; Yucai Li; Bingrong Guo; Fanhui Meng
Journal:  Saudi J Biol Sci       Date:  2020-01-03       Impact factor: 4.219

4.  The Efficacy of Long-Term Chinese Herbal Medicine Use on Lung Cancer Survival Time: A Retrospective Two-Center Cohort Study with Propensity Score Matching.

Authors:  Li-Li Xu; Su-Fang Zhang; Yu-Li Wang; Ying-Bin Luo; Zhi-Hong Fang; Yuan Fang; Rong-Zhong Xu; Peng Guo; Jian-Chun Wu; Yan Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-23       Impact factor: 2.629

5.  Regulatory Mechanism and Experimental Verification of Patchouli Alcohol on Gastric Cancer Cell Based on Network Pharmacology.

Authors:  Yanru Song; Liang Chang; Xiaoyuan Wang; Bibo Tan; Jianbo Li; Jie Zhang; Fengbin Zhang; Lianmei Zhao; Guangjie Liu; Bingjie Huo
Journal:  Front Oncol       Date:  2021-09-01       Impact factor: 6.244

Review 6.  Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models.

Authors:  Hongkui Chen; Min Zheng; Wenhui Zhang; Yuan Long; Yu Xu; Man Yuan
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-21       Impact factor: 2.650

Review 7.  Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery.

Authors:  Jinkyung Park; Dahee Jeong; Meeryoung Song; Bonglee Kim
Journal:  Antioxidants (Basel)       Date:  2021-03-27

Review 8.  Kynurenines as a Novel Target for the Treatment of Malignancies.

Authors:  Adrian Mor; Anna Tankiewicz-Kwedlo; Dariusz Pawlak
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.